U.S. Senate · 118th Congress · S. 1250
Drug-price Transparency for Consumers Act of 2023
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Richard J. DurbinD-IL
- Introduced
- April 20, 2023, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (8)
5 Democrats, 3 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Tammy BaldwinD-WI
- Richard BlumenthalD-CT
- Mike BraunR-IN
- Chuck GrassleyR-IA
- Angus S. King, Jr.D-ME
- J.D. VanceR-OH
Signed on later
- Sherrod BrownD-OHJuly 12, 2023
- Tina SmithD-MNSeptember 7, 2023